✦ LIBER ✦

5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist

✍ Scribed by John E Macor; David H Blank; Kishor Desai; Carol B Fox; B Kenneth Koe; Lorraine A Lebel; Ronald J Post; Anne W Schmidt; David W Schulz; Patricia A Seymour

Book ID: 108038900
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 363 KB
Volume: 5
Category: Article
ISSN: 0960-894X
DOI: 10.1016/0960-894x(95)00417-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: 5-Cyano-1-(3-(N-met

ChemInform Abstract: 5-Cyano-1-(3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl)benzimidazole ( CP-161,242): A Potent, Centrally Active 5-HT1D Receptor Agonist and Benzodiazepine Partial Agonist.

✍ J. E. MACOR; D. H. BLANK; K. DESAI; C. B. FOX; B. K. KOE; L. A. LEBEL; R. J. POS 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB

N -[3-(2-Dimethylaminoethyl)-2-methyl-1

N -[3-(2-Dimethylaminoethyl)-2-methyl-1 H - indol-5-yl]-4-fluorobenzamide: A Potent, Selective, and Orally Active 5-HT 1F Receptor Agonist Potentially Useful for Migraine Therapy

✍ Xu, Yao-Chang; Johnson, Kirk W.; Phebus, Lee A.; Cohen, Marlene; Nelson, David L 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 62 KB

Discovery of 4-[3-( trans -3-Dimethylami

Discovery of 4-[3-( trans -3-Dimethylaminocyclobutyl)-1 H -indol-5-ylmethyl]- (4 S )-oxazolidin-2-one (4991W93), a 5HT 1B/1D Receptor Partial Agonist and a Potent Inhibitor of Electrically Induced Plasma Extravasation

✍ Jandu, Karamjit Singh; Barrett, Vikki; Brockwell, Michael; Cambridge, David; Far 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 217 KB

Structure–Activity Relationship Study of

Structure–Activity Relationship Study of N 6 -(2-(4-(1 H -Indol-5-yl)piperazin-1-yl)ethyl)- N 6 -propyl-4,5,6,7-tetrahydrobenzo[ d ]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization

✍ Johnson, Mark; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K. 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 918 KB

Correction to Structure–Activity Relatio

Correction to Structure–Activity Relationship Study of N 6 -(2-(4-(1 H -Indol-5-yl)piperazin-1-yl)ethyl)- N 6 -propyl-4,5,6,7-tetrahydrobenzo[ d ]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization

✍ Johnson, Mark; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K. 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 197 KB

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views